Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies

Par un écrivain mystérieux
Last updated 10 juillet 2024
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
The Biological Role of Inflammation in Atherosclerosis - Canadian Journal of Cardiology
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
ABC Cardiol
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
PDF) Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
IJMS, Free Full-Text
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Atherosclerosis Nature Reviews Disease Primers
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Biomarkers of Vascular Inflammation for Cardiovascular Risk Prognostication: A Meta-Analysis
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Implication of TAC over CAC in reclassifying risk in intermediate risk

© 2014-2024 escolcontabil.com.br. Inc. ou ses affiliés.